Company Filing History:
Years Active: 2004
Title: Innovator Spotlight: Jolanda Maas and Her Nucleic Acid Amplification Patent
Introduction
Jolanda Maas is a talented inventor based in Amsterdam, Netherlands, renowned for her innovative work in the field of molecular biology. With a focus on advancing techniques for nucleic acid amplification, she has contributed significantly to the scientific community through her patent.
Latest Patents
One of Jolanda's notable patents is for a "Universal nucleic acid amplification system for nucleic acids in a sample." This innovative method involves amplifying nucleic acid in a sample by providing it with a set of primers. These primers are designed to synthesize at least one nucleic acid strand that is complementary to part of the existing nucleic acid. The uniqueness of this method lies in its use of a set of primers that contains between 3-8 random bases, preferably clustered near the 3′ end. The applications for this invention are vast, particularly in determining the presence of pathogens in samples from humans, mammals, poultry, or fish, as well as for typing pathogens and analyzing gene expression profiles.
Career Highlights
Jolanda is affiliated with Primagen Holding B.V., a company dedicated to developing advanced diagnostic solutions. Throughout her career, she has focused on making significant strides in laboratory techniques that enhance the understanding and processing of genetic materials. Her commitment to innovation has established her as a respected figure in her field.
Collaborations
At Primagen Holding B.V., Jolanda has worked alongside notable colleagues, including Jing Zhang and John Dekker. These collaborations enrich her research and contribute to the collective advancement of their projects in nucleic acid technologies.
Conclusion
Jolanda Maas exemplifies the spirit of innovation in the field of molecular biology. Her patent for a universal nucleic acid amplification system showcases her dedication to improving diagnostic methodologies. As she continues her work at Primagen Holding B.V., her contributions are set to leave a lasting impact on both research and practical applications in medical diagnostics.